PRESS RELEASE published on 01/19/2024 at 23:05, 10 months 1 day ago ROSEN, A LEADING NATIONAL FIRM, Encourages British American Tobacco p.l.c. Investors to Inquire About Securities Class Action Investigation - BTI The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of British American Tobacco p.l.c. (NYSE: BTI) shareholders for possible misleading business information. Shareholders who have purchased British American Tobacco securities may be entitled to compensation without payment of any out-of-pocket fees or costs through a contingency fee arrangement. To join the prospective class action seeking recovery of investor losses, individuals can visit their website or contact their toll-free number or email for more information. The Rosen Law Firm has a successful track record in securities class actions and shareholder derivative litigation, including achieving the largest ever securities class action settlement against a Chinese Company and recovering hundreds of millions of dollars for investors. Rosen Law Firm Securities Class Action Investor Rights British American Tobacco Shareholder Compensation
PRESS RELEASE published on 01/19/2024 at 23:04, 10 months 1 day ago ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages ON Semiconductor Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - ON The Rosen Law Firm, a leading global investor rights law firm, encourages ON Semiconductor Corporation investors to secure counsel before the important deadline in the securities class action. If you purchased onsemi common stock during the Class Period, you may be entitled to compensation. The Rosen Law Firm has a track record of success in leadership roles and represents investors worldwide. Act now to protect your rights and seek qualified counsel. Rosen Law Firm Securities Class Action Investor Rights ON Semiconductor Corporation Compensation
PRESS RELEASE published on 01/19/2024 at 22:02, 10 months 1 day ago ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brooge Energy Limited Investors to Inquire About Securities Class Action Investigation - BROG The Rosen Law Firm, a global investor rights law firm, is investigating potential securities claims on behalf of shareholders of Brooge Energy Limited. The firm believes that Brooge may have issued misleading business information to the investing public, resulting in potential financial losses for investors. Interested investors are encouraged to contact the firm to inquire about joining the prospective class action and seeking recovery of investor losses without payment of any out-of-pocket fees or costs. Through its extensive experience and successful track record, The Rosen Law Firm has recovered substantial amounts for investors in securities class actions and shareholder derivative litigation, making them a reliable choice for investors seeking legal representation in such matters. Rosen Law Firm Investor Rights Securities Claims Brooge Energy Limited Class Action Investigation
PRESS RELEASE published on 01/19/2024 at 22:02, 10 months 1 day ago ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages LivePerson, Inc. Investors to Secure Counsel Before Important January 30 Deadline in Securities Class Action - LPSN Rosen Law Firm, a global investor rights law firm, encourages LivePerson, Inc. investors to secure counsel before the important January 30 deadline in the securities class action. The lawsuit alleges misleading statements and withholding of material information by LivePerson, leading to financial damages for investors. Investors may be entitled to compensation and are urged to seek qualified counsel to protect their rights. Rosen Law Firm Securities Class Action Investor Rights LivePerson Inc. Financial Damages
PRESS RELEASE published on 01/19/2024 at 21:04, 10 months 1 day ago ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages BioNTech SE Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BNTX The Rosen Law Firm, a global investor rights law firm, has announced the filing of a class action lawsuit on behalf of BioNTech SE investors. The lawsuit alleges that BioNTech made materially false and misleading statements regarding its business and operations, overstating demand for its COVID-19 vaccine and accumulating excess inventory. Investors who purchased BioNTech securities during the specified period may be entitled to compensation and are encouraged to seek qualified counsel before the March 12, 2024 deadline. Rosen Law Firm BioNTech SE Securities Class Action Investor Rights COVID-19 Vaccine
Published on 11/21/2024 at 14:00, 15 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 15 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 15 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 13:30, 45 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 12:35, 1 hour 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 2 hours ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 55 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 30 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo